Table 1.
Patient demographics and vital signs at baseline
| Characteristic | Unit | Total (n = 294) |
|---|---|---|
| Age, years | Median (range) | 33.5 (18–74) |
| Sex | ||
| Male | n (%) | 139 (47.3) |
| Female | n (%) | 155 (52.7) |
| BMI, kg/m2 | ||
| Male | Median (range) | 24 (17.3–48.3) |
| Female | Median (range) | 24 (15.3–95.3) |
| Systolic blood pressure, mm Hg | ||
| Male | Median (range) | 125 (100–165) |
| Female | Median (range) | 120 (90–189) |
| Diastolic blood pressure, mm Hg | ||
| Male | Median (range) | 78 (55–110) |
| Female | Median (range) | 80 (45–118) |
| Biologic-naive | ||
| Yes | n (%) | 243 (82.7) |
| No | n (%) | 51 (17.3) |
| Nicotine abuse | ||
| Yes | n (%) | 93 (31.6) |
| Patients with tuberculosis | n (%) | 0 (0) |
| Patients with fistulae | ||
| Anal fistula | n (%) | 28 (9.5) |
| Rectovaginal fistula | n (%) | 1 (0.3) |
| Intra-abdominal and enterocutaneous fistula | n (%) | 6 (2.0) |
| Anal fissure | n (%) | 11 (3.7) |
| Concomitant medication | ||
| Azathioprine | n (%) | 91 (31.0) |
| Methotrexate | n (%) | 19 (6.5) |
| Cortisone | n (%) | 17 (5.8) |
| Prednisolone | n (%) | 18 (43.5) |